Company Filing History:
Years Active: 2009-2011
Title: Simone Shoenwaelder: Innovator in Anti-Thrombotic Therapy
Introduction
Simone Shoenwaelder is a prominent inventor based in Victoria, Australia. She has made significant contributions to the field of pharmacology, particularly in the development of anti-thrombotic therapies. With a total of two patents to her name, her work is paving the way for innovative treatments in this critical area of medicine.
Latest Patents
Simone's latest patents focus on the inhibition of phosphoinositide 3-kinase β. The present invention relates to selective inhibitors of phosphoinositide (PI) 3-kinase β, which are used in anti-thrombotic therapy. Additionally, her patents include a method for screening compounds that are useful for new anti-thrombotic therapies by detecting the selective inhibitory activity of PI 3-kinase β. The invention also encompasses novel compounds that act as inhibitors of PI 3-kinase.
Career Highlights
Simone is currently employed at AstraZeneca AB, where she continues to advance her research and development efforts. Her work is instrumental in creating new therapeutic options for patients at risk of thrombotic events.
Collaborations
Some of her notable coworkers include Shaun P. Jackson and Alan Duncan Robertson. Their collaborative efforts contribute to the innovative environment at AstraZeneca, fostering advancements in medical research.
Conclusion
Simone Shoenwaelder is a key figure in the field of anti-thrombotic therapy, with her patents reflecting her commitment to improving patient outcomes. Her work exemplifies the impact of innovation in medicine and the importance of collaboration in research.